Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Erdmann

Showing results (71-80 of 72) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 72 results.
Oncogene|January 19, 2016
Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomasM K Bognar, M Vincendeau, T Erdmann, et al.
Leukemia|February 25, 2015
Anti-CD22 and anti-CD79B antibody drug conjugates are active in different molecular diffuse large B-cell lymphoma subtypesM Pfeifer, B Zheng, T Erdmann, et al.
Pageof 8

Showing results (71-80 of 72) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 72 results.
Oncogene|January 19, 2016
Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomasM K Bognar, M Vincendeau, T Erdmann, et al.
Leukemia|February 25, 2015
Anti-CD22 and anti-CD79B antibody drug conjugates are active in different molecular diffuse large B-cell lymphoma subtypesM Pfeifer, B Zheng, T Erdmann, et al.
Pageof 8